CASI Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $29.3M | $96.2M | $47.1M |
| FY2023 | $51.1M | $75.3M | $17.1M |
| FY2024 | $51.8M | $53.7M | $13.5M |
| FY2025 | $62.9M | $25.7M | $5.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $29.3M | $96.2M | $47.1M |
| FY2023 | $51.1M | $75.3M | $17.1M |
| FY2024 | $51.8M | $53.7M | $13.5M |
| FY2025 | $62.9M | $25.7M | $5.6M |